Does inflammatory linear verrucous epidermal nevus represent a segmental type 1/type 2 mosaic of psoriasis?

Dermatology

Volumn 212, Issue 2, 2006, Pages 103-107

  Hofer, Thomas ^a,b  

^a Dermatology and Venereology FMH ^*

^b Dermatology and Venereology FMH   (Germany)

Author keywords

Epigenetic; Inflammatory linear verrucous epidermal nevus (ILVEN); Linear psoriasis; Nevoid psoriasis, heritability; Postzygotic mutation; Segmental type 1 type 2 mosaic

Indexed keywords

ARTICLE; CASE REPORT; FAMILY HISTORY; FEMALE; HERITABILITY; HUMAN; HYPOTHESIS; LINEAR PSORIASIS; MOSAICISM; NEVUS; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIASIS; SYNDROME ILVEN;

ADMINISTRATION, TOPICAL; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DIHYDROXYCHOLECALCIFEROLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEVUS; OINTMENTS; PSORIASIS; SKIN NEOPLASMS;

EID: 32944469830     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090648     Document Type: Article

References (37)

1. Krueger JG, Bowcock A: Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64(suppl 2):ii30-ii36.
2. Bowcock AM, Barker JN: Genetics of psoriasis: The potential impact on new therapies. J Am Acad Dermatol 2003;49:S51-S56.
3. Henseler T, Christophers E: Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-456.
4. Atherton DJ, Kahana M, Russel-Jones R: Naevoid psoriasis. Br J Dermatol 1989;120:837-841.
5. Yu HJ, Ko JY, Kwon HM, Kim JS: Linear psoriasis with porokeratotic eccrine ostial and dermal duct nevus. J Am Acad Dermatol 2004;50:S81-S83.
6. Ghorpade A: Linear naevoid psoriasis along lines of Blaschko. J Eur Acad Dermatol Venereol 2004;18:726-727.
7. Beek CH, Jantzen J: On acute linear dermatoses. Acta Derm Venereol 1955;35:319-326.
8. Leslie G: Linear psoriasis. Br J Dermatol 1951;63:262-263.
9. Saraswat A, Sandhu K, Shukla R, Handa S: Unilateral linear psoriasis with palmoplantar, nail and scalp involvement. Pediatr Dermatol 2004;21:70-73.
10. Kaidbey KH, Kurban AK: Dermatitic epidermal nevus. Arch Dermatol 1971;104:166-171.
11. Altman J, Mehregan AH: Inflammatory linear verrucous epidermal nevus. Arch Dermatol 1971;104:385-389.
12. Happle R: What is a nevus? A proposed definition of a common medical term. Dermatology 1995;191:1-5.
13. Al-Enezi S, Huber AM, Krafchik BR, Laxer RM: Inflammatory linear verrucous epidermal nevus and arthritis: A new association. J Pediatr 2001;138:602-604.
14. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina MA, Young M, Lory D, Morris L, Wuepper KD, Stastny P, Menter A, Bowcock A: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-1145.
15. Goldman K, Don PC: Adult onset of inflammatory linear verrucous epidermal nevus in a mother and her daughter. Dermatology 1994;189:170-172.
16. Hamm H, Happle R: Inflammatory linear verrucous epidermal nevus in a mother and her daughter. Am J Med Genet 1986;24:685-690.
17. Alsaleh QA, Nanda A, Hassab-el-Naby HMM, Sakir MF: Familial inflammatory linear verrucous epidermal nevus (ILVEN). Int J Dermatol 1994;33:52-54.
18. Moulin G, Biot A, Valignat P, Bouchet B, Meunier F: Naevus épidermique verruqueux inflammatoire familial. Bull Soc Fr Dermatol Syphilol 1975;82:130-131.
19. Lee SH, Rogers M: Inflammatory linear verrucous epidermal naevi: a review of 23 cases. Australas J Dermatol 2001;42:252-256.
20. Oram Y, Arisoy AE, Hazneci E, Gürer I, Müezzinoglu B, Arisoy ES: Bilateral inflammatory linear verrucous epidermal nevus associated with psoriasis. Cutis 1996;57:275-278.
21. Menni S, Restano L, Gianotti R, Boccardi D: Inflammatory linear verrucous nevus (ILVEN) in a child? Int J Dermatol 2000;39:30-40.
22. Rulo HFC, van de Kerkhof PCM: Treatment of inflammatory linear verrucous epidermal nevus. Dermatologica 1991;182:112-114.
23. Böhm I, Biber T, Bauer R: Erfolgreiche Therapie eines ILVEN bei einem 7-jährigen Mädchen mit Calcipotriol. Hautarzt 1999;50:812-814.
24. 3. Br J Dermatol 1997;136:134-135.
25. Gatti S, Carrozzo AM, Orlandi A, Nini G: Treatment of inflammatory linear verrucous epidermal naevus with calcipotriol. Br J Dermatol 1995;132:837-838.
26. Lipsker D, Cribier B, Girard-Lemaire F, Flori E, Grosshans E: Genetic mosaicism in an acquired inflammatory dermatosis following the lines of Blaschko. Arch Dermatol 2000;136: 805-807.
27. Cosun B, Saral Y, Ozturk P, Karincaoglu Y, Cobanoglu B: Calcium acetate-induced linear fixed drug eruption. Dermatology 2005;210:244-245.
28. Yokozeki H, Ueno M, Komori K, Nishioka K: Multiple linear erythema dyschronicum perstans (ashy dermatosis) in the lines of Blaschko. Dermatology 2005;210:356-357.
29. Happle R: Segmentale Typ-2-Manifestation autosomal dominanter Hautkrankheiten: Entwicklung eines neuen formalgenetischen Konzeptes. Hautarzt 2001;52:283-287.
30. Happle R: Akanthokeratolytischer epidermaler Nävus: Vererbbar ist die Akanthokeratolyse, nicht der Nävus. Hautarzt 1990;41:117-118.
31. Happle R, Mittag H, Küster W: The CHILD nevus: a distinct skin disorder. Dermatology 1995;191:210-216.
32. Poblete-Gutierrez P, Wiederholt T, König A, Jugert FK, Marquardt Y, Rubben A, Merk HF, Happle R, Frank J: Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004;114:1467-1474.
33. Happle R: Loss of heterozygosity in human skin. J Am Acad Dermatol 1999;41:143-164.
34. Happle R: Somatic recombination may explain linear psoriasis. J Med Genet 1991;28:337.
35. Lever WF, Schaumburg-Lever G: Non-infectious erythematous, papular and squamous diseases; in Lever WF, Schaumburg-Lever G (eds): Histopathology of the Skin, ed 6. Philadelphia, Lippincott, 1983, pp 158-159.
36. Schnyder UW: Tumoren der Haut; in Doerr W, Seifert G, Uehlinger E (eds): Spezielle pathologische Anatomie - Histopathologie der Haut, ed 2. Berlin/Heidelberg, Springer, 1979, Band 7, Teil 2: Stoffwechselkrankheiten und Tumoren, pp 97-99.
37. Happle R: Transposable elements and the lines of Blaschko: a new perspective. Dermatology 2002;204:4-7.